The abstract is read at the publisher; the summary is JClub's.
A first integrative multiomics atlas of the human LAM niche identifies three LAM CORE subtypes, including a fibroblast-like CORE2 with potent extracellular matrix remodelling activity.
- Why it matters: Sirolimus stabilizes lung function in most LAM patients but does not eliminate LAM cells, leaving unclear how tumour microenvironment heterogeneity supports progression.
- What they did: The study integrates single-cell/single-nucleus RNA-seq, single-nucleus ATAC-seq, and spatial transcriptomics, then validates findings with multimodal imaging to map LAM and LAF states.
- The result: Spatial mapping shows a structured ecosystem where LAM CORE1 forms a central core enmeshed with lymphatic endothelium and surrounded by LAFs, CORE2 cells, and reprogrammed immune/epithelial cells.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.